Oxaliplatin-induced neuropathy: the preventive effect of a new super-oxide dismutase modulator.
cancer cell
chemotherapy toxicities
oxaliplatine
oxidative stress
super oxide dismutase
Journal
Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965
Informations de publication
Date de publication:
05 Nov 2019
05 Nov 2019
Historique:
received:
30
07
2019
accepted:
10
09
2019
entrez:
20
11
2019
pubmed:
20
11
2019
medline:
20
11
2019
Statut:
epublish
Résumé
By using the differential in level of oxidative status between normal and cancer cells, SuperOxide Dismutase (SOD) mimetics can have anti-tumor efficacy and prevent oxaliplatin-induced peripheral neuropathy. Our objective was to evaluate the neuroprotective efficacy of MAG, a new SOD mimic.
Identifiants
pubmed: 31741707
doi: 10.18632/oncotarget.27248
pii: 27248
pmc: PMC6849645
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6418-6431Informations de copyright
Copyright: © 2019 Guillaumot et al.
Déclaration de conflit d'intérêts
CONFLICTS OF INTEREST The author(s) received no specific funding for this work.
Références
EMBO Mol Med. 2011 May;3(5):266-78
pubmed: 21438154
Cancer Res. 2005 Feb 1;65(3):948-56
pubmed: 15705895
Diabetologia. 1996 Mar;39(3):263-9
pubmed: 8721770
Cancer Res. 2000 Jul 15;60(14):3927-39
pubmed: 10919671
Mol Cancer Ther. 2017 Feb;16(2):300-311
pubmed: 27980107
Am J Transl Res. 2017 Mar 15;9(3):926-939
pubmed: 28386322
Psychopharmacology (Berl). 2012 Mar;220(1):183-93
pubmed: 21894483
Cancer. 2013 Jan 15;119(2):438-44
pubmed: 22786764
Mol Pain. 2009 Feb 26;5:9
pubmed: 19245717
Neurology. 2007 Jul 3;69(1):42-9
pubmed: 17606879
Cell Signal. 1999 Jan;11(1):1-14
pubmed: 10206339
PLoS One. 2009 Nov 13;4(11):e7754
pubmed: 19915661
J Neurol. 2015 Jan;262(1):203-12
pubmed: 25371017
Redox Biol. 2014 Jan 18;2:289-95
pubmed: 24494204
J Natl Cancer Inst. 2006 Feb 15;98(4):236-44
pubmed: 16478742
J Neurosci. 2010 Jun 30;30(26):8953-64
pubmed: 20592216
Mutat Res. 2001 Jun 2;477(1-2):7-21
pubmed: 11376682
Nat Rev Drug Discov. 2009 Jul;8(7):579-91
pubmed: 19478820
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1755-60
pubmed: 15665080
Neuroscience. 1982 Jun;7(6):1335-66
pubmed: 6289166
Dalton Trans. 2012 Jun 7;41(21):6399-403
pubmed: 22407398
J Peripher Nerv Syst. 2009 Mar;14(1):45-53
pubmed: 19335539
Free Radic Res. 1995 Nov;23(5):471-86
pubmed: 7581830
Biochim Biophys Acta. 2012 May;1822(5):794-814
pubmed: 22198225
J Clin Oncol. 2002 Aug 15;20(16):3478-83
pubmed: 12177109
Zhonghua Yi Xue Za Zhi. 2016 Apr 5;96(13):1021-5
pubmed: 27055794
Nat Genet. 1995 Nov;11(3):274-80
pubmed: 7581450
Pain. 2007 Oct;131(3):262-71
pubmed: 17317010
J Clin Invest. 2014 Jan;124(1):262-72
pubmed: 24355920
Antioxid Redox Signal. 2014 May 20;20(15):2372-415
pubmed: 23875805
Bioorg Chem. 2011 Apr;39(2):73-87
pubmed: 21397291
Inorg Chem. 2017 Mar 6;56(5):2545-2555
pubmed: 28198622
Nature. 1997 Sep 18;389(6648):300-5
pubmed: 9305847
Pharmacol Res. 2007 Feb;55(2):158-66
pubmed: 17207636
Neurology. 1984 Jul;34(7):934-8
pubmed: 6330613
Semin Oncol. 1998 Apr;25(2 Suppl 5):4-12
pubmed: 9609103
Drug Discov Today. 2015 Apr;20(4):411-21
pubmed: 25463039
Front Pharmacol. 2013 Dec 18;4:156
pubmed: 24385965
Anesthesiology. 2014 Feb;120(2):459-73
pubmed: 24064792
J Neurosci. 2009 Feb 25;29(8):2519-27
pubmed: 19244526
J Pharmacol Exp Ther. 2001 Jan;296(1):1-6
pubmed: 11123355
Biofactors. 2011 May-Jun;37(3):168-74
pubmed: 21698696
Pulm Pharmacol Ther. 2002;15(5):439-47
pubmed: 12406666
PLoS One. 2017 Jul 21;12(7):e0180953
pubmed: 28732061
Hypertension. 2007 Apr;49(4):717-27
pubmed: 17296874
Atmos Environ (1994). 2011 Nov;45(40):7555-7562
pubmed: 22125412
Acta Oncol. 2018 Mar;57(3):393-402
pubmed: 29140155
J Oncol Pract. 2014 Nov;10(6):e421-e424
pubmed: 29424607
Nat Protoc. 2008;3(1):8-21
pubmed: 18193017
Support Care Cancer. 2014 Jul;22(7):1999-2007
pubmed: 24728618
Cancer Manag Res. 2014 Mar 19;6:135-47
pubmed: 24672257
Transl Oncol. 2012 Dec;5(6):492-502
pubmed: 23323161